logo

PTCT

Ptc Therapeutics·NASDAQ
--
--(--)
--
--(--)

PTCT fundamentals

Ptc Therapeutics (PTCT) expects to report earnings on Feb 19, 2026, with estimated revenue of 279.48M (YoY +31.11%), and EPS at 0.1032 (YoY +112.14%).
Revenue estimate / YoY
279.48M
+31.11%
EPS estimate / YoY
0.1032
+112.14%
Report date
Feb 19, 2026
Earnings Call
4:30 PM on Feb 19, 2026
Meeting link.
EPS
Revenue

Revenue & Expenses

PTCT has released its 2025 Q3 earnings report, with revenue of 211.01M, reflecting a YoY change of 7.23%, and net profit of 15.90M, showing a YoY change of 114.90%. The Sankey diagram below clearly presents PTCT's revenue sources and cost distribution.

Key Indicators

Ptc Therapeutics (PTCT) key financial stats and ratios, covering profitability, financial health, and leverage.
Ptc Therapeutics (PTCT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Ptc Therapeutics (PTCT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Ptc Therapeutics (PTCT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Ptc Therapeutics (PTCT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Ptc Therapeutics (PTCT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield